Physician

Amanda Kaveney, MD

According to 2025 Medicare claims, Amanda Kaveney, MD (NPI: 1508154162) practices hematology/oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (NPI: 1508938119; TIN: 223371727) and primary practice location at 08901-1928. Kaveney is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Kaveney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 123 traditional Medicare patients, billed 367 HCPCS/CPT codes, and received $35,853 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 181 prescription claims across 40 beneficiaries totaling $156,044 in drug costs, led by Eliquis (Apixaban). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $7,848 to $156,044. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	43	179	$13,919
2016	139	503	$42,163
2017	149	586	$47,556
2018	171	665	$55,080
2019	156	511	$46,171
2020	137	422	$42,226
2021	145	402	$46,865
2022	138	359	$37,644
2023	122	354	$38,312
2024	123	367	$35,853

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	27	$7,848
2016	16	73	$219,053
2017	32	143	$479,258
2018	38	214	$639,675
2019	41	244	$742,032
2020	41	198	$614,609
2021	47	236	$530,583
2022	48	252	$625,581
2023	41	217	$293,177
2024	40	181	$156,044

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	31	32	$146
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	59	94	$137
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	43	113	$98
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	22	47	$63
36415	Insertion of needle into vein for collection of blood sample	20	36	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	93	4,405	$82,979
Xarelto	Rivaroxaban	68	3,570	$65,348

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Amanda Kaveney, MD?

Tedicare shows public-source Medicare data for Amanda Kaveney, MD (NPI 1508154162), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda Kaveney, MD have ACO affiliation data?

Amanda Kaveney, MD is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Amanda Kaveney, MD?

Amanda Kaveney, MD is linked to RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (billing NPI 1508938119) in the available physician profile data.

Does Amanda Kaveney, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.